Metabolic Syndrome with Different Antipsychotics: A Multicentre Cross-Sectional Study
When metabolic parameters evaluated overall, metabolic risk with antipsychotics is found to be highest in clozapine group, followed by combined AP group. Olanzapine and risperidone have intermediate risk while zuclopentixole has lowest.
Authors
- Cem Cerit (ORCID: https://orcid.org/0000-0002-0189-7003)
- Meltem Vural (ORCID: https://orcid.org/0000-0003-4360-8318)
- Eylem Özten (ORCID: https://orcid.org/0000-0002-5896-0798)
- Ahmet Aker (ORCID: https://orcid.org/0000-0003-3381-0790)
- Mustafa Yıldız (ORCID: https://orcid.org/0000-0003-0769-1628)
- Şükriye Boşgelmez (ORCID: https://orcid.org/0000-0003-0529-9067)
Institutions
- Haydarpaşa Numune Eğitim ve Araştırma Hastanesi (TR)
Publication Details
- Journal
- Psychopharmacology Bulletin
- Published
- 2025-08-12
- DOI
- https://doi.org/10.64719/pb.4301
- Citations
- 20
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00